Method for predicting clinical benefit in the treatment of neurodesenvolvimento neurological or neuropsychiatric disorders.

摘要

Abstract invention patent: "method to predict clinical benefit in the treatment of disorders of neurodesenvolvimento, neurological or neuropsychiatric.The invention relates to a method of in vitro provide an answer for patients with neurological or neuropsychiatric disorders, neurodesenvolvimento, is treated with a compound that has targeted the use glutamatu00e9rgica, comprising the steps of: I) to determine the concentration of prote u00edna of one, two, three, four.Five or six members of the family of factors of complement h or a mixture or a combination thereof, in a sample of a patient, (II) to compare the concentration of protein determined in step (I) with a value representative of the concentration of protein A, two, three, four, five... Or six members of the family of factors working h in patients with disorders of neurodesenvolvimento,Neurological or neuropsychiatric, (III), in which a greater concentration of protein with one, two, three, four, five or six members of the family of factors working in the sample of the patient who presents h neurodesenvolvimento disorders, neurological or neuropsychiatric is indicat Vat of a patient who will obtain clinical benefit of this treatment.And (IV) selecting this treatment to patients with disorders of neurodesenvolvimento, neurological or neuropsychiatric.